Performance Risk Is Now Revenue Risk in Specialty Care
-
June 12, 2026
-
For decades, specialist providers were driven by volume. The model is rapidly shifting to outcomes-based, introducing new financial exposure that many organizations are unprepared to manage.
CMS reforms are accelerating this transition. Under emerging models such as the Ambulatory Specialty Model (“ASM”), physician performance will increasingly be evaluated based on episode costs and quality outcomes. For providers, reimbursement will now be tied to how effectively conditions including heart failure and low back pain are managed.
While many organizations recognize that specialty reimbursement is changing, far fewer understand how it could reshape revenue, physician performance and strategic decision-making. Starting in 2027, CMS will expand specialty accountability through performance-based reimbursement structures.1 The data that will drive payments and physician evaluation and influence future reimbursements is already being collected.
This is not a reimbursement shift. It’s an economic model shift. Under these models, even small performance differences will translate into meaningful revenue impact.
As a result, organizations may experience meaningful reimbursement variation depending on how effectively they manage conditions such as heart failure and low back pain. Financial performance now relies on quality metrics, patient outcomes and total cost of care. Both public and private markets are aligning reimbursement, referrals and partnerships with measurable outcomes, efficiency and value.
Many organizations are aware that specialty reimbursement is changing. Far fewer understand how those changes could affect future revenue, physician performance evaluations and strategic decision-making.
Organizations that act early to understand and manage variance will be best positioned to compete.
Why Specialists Are Moving to the Center of Value-Based Care
For cardiologists and orthopedic surgeons, the system now demands deeper collaboration with primary care to prevent major and episodic health events. The goal: Collectively prevent or reduce the impact of high-cost, high-volume chronic conditions including heart failure and low back pain.
Specialists who once answered, “Were services delivered?” must now show, “Did the intervention create value?” Those who operated alongside value-based care will now be central to it.
This fundamentally changes how specialists win or lose financially. Why?
Specialists will now carry direct financial accountability through bundled payments, quality reporting and shared risk arrangements.
Specialists must now reassess key aspects of their practice, including:
- Operational strategy
- Care coordination expectations
- Interoperability with hospitals and other providers
- Profitability models
Specialists will need to determine how these complex new and overlapping regulatory frameworks will impact their revenue and what changes will be needed to optimize their operations. Lower-performing specialists may face heightened scrutiny from payers, reduced leverage in network negotiations and greater pressure from health-system partners focused on cost and quality.
The future of specialty care will favor providers who can maximize economic value through measurable outcomes, efficient care delivery and the ability to adapt to new reimbursement models.
Understanding the Financial Impact of Value-Based Care
Providers may underestimate the financial impact of value-based care if they don’t have access to advanced modeling that manages risk across diverse patient populations.
CMS is moving from basic cost control to managing specific patient populations. Specialists and Health Systems that employ such specialists must grasp how reimbursement and new contracts will affect financial performance. Many contracts last three to five years. Operational decisions made today may influence performance under future reimbursement models for years to come.
Many specialists lack the internal resources or expertise to model financial risk and opportunity across changing patient populations. However, skipping the modeling step because of the problem's complexity will likely lead to a suboptimal strategy.
External experts can help specialists build a clearer picture of financial exposure, operational risk and performance opportunities. By integrating financial, operational and clinical analysis, organizations can identify where to focus resources, which patient segments need more attention and which operational changes are most likely to improve performance under value-based care models.
Strategy begins with understanding how change reshapes revenue, risk and performance.
Illustrative Example: Looking Beyond Average Performance
A fictitious cardiology group initially appears well positioned for success under a value-based reimbursement model.
| Metric | Result |
|---|---|
| Participating Physicians | 12 |
| Heart Failure Episodes | 850 |
| Average Episodes per Physician | 71 |
| Quality Scores | Above Average |
| Average Episode Costs | Slightly Above Benchmark |
At first glance, leadership assumes the financial impact will be minimal. Quality performance is strong, and overall costs appear reasonably aligned with peers.
However, a deeper analysis reveals several troubling operational factors that are not immediately visible in high-level reports:
- Higher HOPD utilization
- Significant referral leakage
- Wide variation in practice patterns across physicians
While performance appeared relatively stable, a deeper dive surfaced variation across its 12 participating physicians. Because the organization managed approximately 850 heart failure episodes annually, even a $300-$600 difference in performance per episode could translate into roughly $250,000-$500,000 of annual reimbursement variation.
| Scenario | Illustrative Financial Impact |
|---|---|
| Favorable Performance | +$250,000 |
| Neutral Performance | ~$0 |
| Unfavorable Performance | -$500,000 |
This illustrative example highlights how seemingly modest differences in episode performance can create meaningful financial variation across participating providers. The analysis helped the organization prioritize the following before performance measurement periods were finalized:
- Site-of-care optimization
- Referral management
- Physician alignment strategies
This example demonstrates that specialty providers must now better understand operational drivers and reevaluate performance metrics to surface potential hidden financial exposure.
Many organizations will not fully understand their performance under ASM until CMS releases performance results, but that’s too late. The ability to influence outcomes may have already passed. Visibility into site-of-care, referral, utilization and physician variation drivers enables the ability to make targeted improvements before performance periods close.
Steps to Prepare for Upcoming Regulations
Many providers view the transition to value-based care as a chicken-and-egg dilemma: Should operational changes come first, or should financial modeling guide decision-making?
The answer is clear. Providers should first assess their potential financial exposure and opportunities before making any operational investments. Without understanding potential reimbursement impact, organizations risk investing in initiatives that do not improve performance.
After quantifying financial impact, organizations need a deeper understanding of patient populations, provider performance and historical claims data. Leading organizations use this analysis to target operational changes that improve compliance and future reimbursement.
To establish a baseline for 2027 performance, specialists should:
- Analyze 2024 and 2025 claims data to identify patients with episodes of heart failure or low back pain.
- Determine which providers exceeded the minimum case-volume thresholds.
- Review CMS eligibility criteria.
- Evaluate physician-level variation in episode performance.
- Assess site-of-care patterns, referral leakage, and utilization drivers.
- Model a range of reimbursement scenarios to understand potential financial implications.
The question is no longer whether specialty reimbursement is changing, but whether organizations understand how those changes may affect them. As CMS expands accountability for episode cost and quality performance, specialists and health systems that assess their exposure early and align clinical, operational, and financial strategies will be better positioned to succeed in an increasingly value-driven environment.
Footnote:
1 Centers for Medicare & Medicaid Services, “Innovation Center Strategy Refresh” (accessed June 8, 2026).
Related Information
Published
June 12, 2026
Key Contacts